# Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process

> **NCT03922698** · — · UNKNOWN · sponsor: **Neuromed IRCCS** · enrollment: 50 (estimated)

## Conditions studied

- Carotid Atherosclerosis

## Interventions

- **OTHER:** No interventions

## Key facts

- **NCT ID:** NCT03922698
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03922698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03922698, "Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03922698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*